People
For the past four years, the Gloucester Marine Genomics Institute has been leading the charge training workers for a future in the biotech industry through its Biotechnology Academy.
The stated cause of the suspension of enrollment was the occurrence of two intrathecal catheter-related infections that weren’t related to the drug.
According to a company statement, the three employees are doing well and “improving under the care of their healthcare providers.”
Life sciences and pharma companies from across the globe strengthen their leadership teams and board with this week’s Movers & Shakers.
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
Multiple pharma conferences set to take place in the United States this month will proceed as planned, but event organizers are urging precaution against the coronavirus.
Oculis S.A., a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments for ophthalmic diseases, announced the appointment of Marcia de Souza Lima, M.D., M.I.P.P., as Chief Medical Officer.
Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the following changes to its Officers and Board of Directors.
Ghosh succeeds current Unity CEO Keith Leonard, who will step down from his role. Leonard will continue as the chairman of the board of directors.
In addition, the company’s chief scientific officer, Seth Ettenberg, has resigned.
PRESS RELEASES